Philadelphia, April 11 - BioLabs Philadelphia presents BioLabs Investor Day 2024, a curated all-day pitchfest featuring life science startups in various stages of fundraising – from pre-seed to Series B – to make a series of rapid-fire pitches to major pharma and top biotech VCs coming from across the Eastern Seaboard. Additional startups will also participate in an invite-only afternoon poster session, exposing investors, sponsors, and partners to even more opportunities to invest in Philly’s growing life science community.
Along with event partners listed below, BioLabs has curated a now-annual invite-only event that convenes pivotal players in Philly’s life science ecosystem under one historic roof in Center City Philadelphia: The Curtis, former publishing giant turned life science hub.
The agenda includes:
15, 5-minute pitches by life science startups in various stages of development
4 networking breaks
1 panel session
11 partner affiliates: BioStrategy Partners, Children’s Hospital of Philadelphia, Thomas Jefferson University and Jefferson Health, Life Science Cares, Mission BioCapital, Penn Center for Innovation, Penn State, Philadelphia College of Osteopathic Medicine, University City Science Center, Temple University, and The Wistar Institute
Sponsors: CRADL, Breakthrough Properties, Gunderson Dettmer, Thermo Fisher Scientific, Scheer Partners, Revvity, Elemental Machines, Eppendorf, Keystone Properties, Millipore Sigma and Promega
More information can be found on the BioLabs Investor Day website, which is updated regularly
Biolabs' mission is to empower entrepreneurs and drive life science innovation worldwide. BioLabs’ comprehensive innovation support platform provides entrepreneurs access to premium, fully-equipped co-working lab and office facilities, extensive educational programming, a supportive community and connections to a global network of fellow entrepreneurs, collaborators, and capital partners. Currently operating in 15 locations across the US, Europe and Japan, BioLabs accelerates the pace of innovation commercialization by enabling entrepreneurs to focus on science, not operations. This is the 8th Investor Day held by BioLabs worldwide, and the second annual Investor Day at the Philadelphia location.
Contact Information: Melina Blees, BioLabs Philadelphia Site Director, Phone: 530-848-6288; Larissa Mogano, BioLabs Philadelphia Operations and Events Coordinator, 267-342-9919; e-mail: philly@biolabs.io ###